This is an educational video for the prostate cancer patients and their families. Depending on the individual patient, a radical prostatectomy, might be a procedure that your urologist could recommend as treatment. Here is a brief demonstration of this procedure.

LIVE VIDEO: IMMEDIATE ANATOMIC CERAMIC IMPLANT IN 3 MINUTES! dentistry

A very funny medical love song

Robotics is the engineering science and technology of robots, and their design, manufacture, application, and structural disposition.

The superior vena cava is a major vein in a person's body. It carries blood from the head, neck, upper chest, and arms to the heart. Superior vena cava syndrome (SVCS) occurs when a person's superior vena cava is partially blocked or compressed. Cancer is usually the main cause of SVCS.

Parasitic twins: boy carrying dead twin inside him, giant tumor removed - tumors compilation

Thai traditional massage is world renowned to the point of being a global brand

Knee Replacement Surgery Video

Osteochondroma. Osteochondromas (osteocartilaginous exostoses), the most common benign bone tumors, may arise from any bone but tend to occur near the ends of long bones. ... Enchondroma. ... Chondroblastoma. ... Chondromyxofibroma. ... Osteoid osteoma. ... Nonossifying fibroma (fibrous cortical defect) ... Benign giant cell tumor of bone.

A detailed description of the Hepato-pulmonary syndrome including its definition, pathophysiology, diagnosis and treatment. The pathophysiology includes nitric oxide in the pulmonary vasculature which results in intrapulmonary vasodilatation. This causes the classical and unique symptom of platypnea and orthodeoxia.

An AV fistula is a connection, made by a vascular surgeon, of an artery to a vein.Vascular surgeons specialize in blood vessel surgery. The surgeon usually places an AV fistula in the forearm or upper arm. An AV fistula causes extra pressure and extra blood to flow into the vein, making it grow large and strong.

The MAKOplasty® procedure is an FDA-cleared treatment option for patients who suffer from osteoarthritis damage in the medial (inner) portion of the knee. ... Only the diseased portion of your knee is removed, leaving the healthy bone and tissue surrounding it untouched.

Posterior Urethral Strictures Associated with Urinary Incontinence after Prostatectomy Management

Cholecystectomy without General Anesthesia video

Preventing Hemodialysis Catheters Problems

Developmental Milestones: Baby Talk from First Sounds to First Words

The needle should pass through the tissue at a perpendiculaPlace the tips of the left-hand forceps on the underside of the tissue at the point where the needle will enter, and gently push the edge upward. With the right hand, bring the needle into contact with the tissue, and press downward. These movements create eversion. Pass the needle through. Do not grab the tissue with your left hand forceps since it will damage the intima. If needed, you can pick up adventitia or a nearby suture to help with exposure and eversion. r.The needle must pass through the other side at a perpendicular, too. Bring the tip of the needle to the place where you intend to bring it out on the other side. Put the tip of your left-hand forceps on the upper surface of the tissue at the intended exit point. Press down with the left-hand forceps and push up with the needle to give you the correct eversion. The width of the bite should be about three times the thickness of the needle. The bites on both sides must be equal, and the needle should cross exactly in a straight line (not diagonally). Pull the needle through the tissue following the curve of the needle

Histology of Heart Endocardium Pericardium Epicardium

Cytomegalovirus (CMV) continues to have a tremendous impact in solid organ transplantation despite remarkable advances in its diagnosis, prevention and treatment. It can affect allograft function and increase patient morbidity and mortality through a number of direct and indirect effects. Patients may develop asymptomatic viremia, CMV syndrome or tissue-invasive disease. Late-onset CMV disease continues to be a major problem in high-risk patients after completion of antiviral prophylaxis. Emerging data suggests that immunologic monitoring may be useful in predicting the risk of late onset CMV disease. There is now increasing interest in the development of an effective vaccine for prevention. Novel antiviral drugs with unique mechanisms of action and lesser toxicity are being developed. Viral load quantification is now undergoing standardization, and this will permit the generation of clinically relevant viral thresholds for the management of patients. This article provides a brief overview of the contemporary epidemiology, clinical presentation, diagnosis, prevention and treatment of CMV infection in solid organ transplant recipients.